Cross Country Healthcare Q1 revenue down 39% YoY to $379M; net income falls 91%

CROSS COUNTRY HEALTHCARE INC

2024-Q1 EPS reported $0.08 revenue$379,174,000

Revenue $379.2M, down 39% YoY and 8% sequentially.
Net income $2.7M, down 91% YoY; diluted EPS $0.08 vs -$0.73 in Q1 2023.
Adjusted EBITDA $15.3M (margin 4.0%), down 71% YoY; adjusted EPS $0.19.
Cash from operations $6.0M, down 87% YoY.
Gross margin 20.4%, down 200 bps YoY and 150 bps sequentially.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

CROSS COUNTRY HEALTHCARE INC reported first quarter ended March 31, 2024 results: revenue $379,174, net income $2,692, EPS $0.08.

Period: first quarter ended March 31, 2024
Revenue: $379,174
Net income: $2,692
EPS: $0.08
Result: reported results

Exact text from the filing

CROSS COUNTRY HEALTHCARE ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS BOCA RATON, Fla., May 1, 2024--Cross Country Healthcare, Inc. (the “Company”) (Nasdaq: CCRN) today announced financial results for its first quarter ended March 31, 2024. SELECTED FINANCIAL INFORMATION: Variance Variance Q1 2024 vs Q1 2024 vs Dollars are in thousands, except per share amounts Q1 2024 Q1 2023 Q4 2023 Revenue $ 379,174 (39) % (8) % Gross profit margin* 20.4 % (200) bps (150) bps Net income attributable to common stockholders $ 2,692 (91) % (70) % Diluted EPS $ 0.08 $ (0.73) $ (0.18)

View on SEC.gov

379 earnings releases filed in the last 30 days. Browse all earnings releases →

CROSS COUNTRY HEALTHCARE INC filing history →

Source: SEC EDGAR

accession 0001628280-24-019637

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.